Skip to main content
September 12, 2020
Psych Congress 2020 cochair Vladimir Maletic, MD, MS, gives the latest updates on adult-onset attention deficit/hyperactivity disorder (ADHD).
September 12, 2020
Psych Congress 2020 presenter Timothy Wilens, MD, discusses the negative outcomes associated with attention-deficit/hyperactivity disorder (ADHD) that is left untreated.
September 11, 2020
In patients with comorbid chronic pain and substance use disorders, developing protocols for continuing opioid therapy are key for patient safety, W. Clay Jackson, MD, and Arwen Podesta, MD, DFASAM, DFAPA, ABIHM, told Psych Congress 2020 attendees.
September 11, 2020
Patients initiated on long-acting injectables for the treatment of schizophrenia had fewer hospitalizations and emergency department visits, compared with patients treated with oral antipsychotics, according to a poster presented at Psych Congress 2020. 
September 11, 2020
The metabolic profile of lumateperone 42 mg appears favorable, according to a post hoc analysis of a trio of studies involving patients with schizophrenia. Researchers shared their findings at Psych Congress 2020.
September 11, 2020
A 6-month extension of a published short-term trial showed continued improvement with SEP-363856 in patients with schizophrenia, researchers reported in a poster at Psych Congress 2020.
September 11, 2020
A large-scale analysis of insurance databases found a high prevalence of medical and psychiatric comorbidities among patients with schizophrenia, compared with matched controls, according to a poster presented at Psych Congress 2020.
September 11, 2020
In patients with recent-onset schizophrenia, the rate of major treatment failure with longer treatment was lower with paliperidone palmitate than with oral antipsychotics, according to a poster presented at Psych Congress 2020. 
September 11, 2020
HP-3070, the asenapine transdermal system, has a more predictable absorption profile and lower peak-to-trough fluctuations than sublingual asenapine, according to a poster presented at Psych Congress 2020.
September 10, 2020
A general population survey launched in the midst of the COVID-19 pandemic has collected responses from more than 92,000 people in 140 countries, Christoph U. Correll, MD, a co-leader of the project, said during the Psych Congress 2020 welcome session.
Back to Top